Patents by Inventor Jeffrey Van Ness

Jeffrey Van Ness has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9791462
    Abstract: A novel class or family of TGF-? binding proteins is disclosed. Also disclosed are assays for selecting molecules for increasing bone mineralization and methods for utilizing such molecules.
    Type: Grant
    Filed: February 19, 2015
    Date of Patent: October 17, 2017
    Assignee: UCB PHARMA, S.A.
    Inventors: Mary E. Brunkow, David J. Galas, Brian Kovacevich, John T. Mulligan, Bryan W. Paeper, Jeffrey Van Ness, David G. Winkler
  • Publication number: 20160187357
    Abstract: A novel class or family of TGF-? binding proteins is disclosed. Also disclosed are assays for selecting molecules for increasing bone mineralization and methods for utilizing such molecules.
    Type: Application
    Filed: February 19, 2015
    Publication date: June 30, 2016
    Inventors: Mary E. Brunkow, David J. Galas, Brian Kovacevich, John T. Mulligan, Bryan W. Paeper, Jeffrey Van Ness, David G. Winkler
  • Patent number: 8986685
    Abstract: Described herein are pharmaceutical compositions comprising an anti-sclerostin antibody and an inhibitor of bone resorption.
    Type: Grant
    Filed: October 4, 2012
    Date of Patent: March 24, 2015
    Assignee: UCB Pharma S.A.
    Inventors: Mary E. Brunkow, David J. Galas, Brian Kovacevich, John T. Mulligan, Bryan W. Paeper, Jeffrey Van Ness, David G. Winkler
  • Patent number: 7994299
    Abstract: A novel class or family of TGF-? binding proteins is disclosed. Also disclosed are assays for selecting molecules for increasing bone mineralization and methods for utilizing such molecules.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: August 9, 2011
    Assignee: Darwin Discovery Limited
    Inventors: Mary E. Brunkow, David J. Galas, Brian Kovacevich, John T. Mulligan, Bryan W. Paeper, Jeffrey Van Ness, David J. Winkler
  • Patent number: 7977312
    Abstract: A novel class or family of TGF-? binding proteins is disclosed. Also disclosed are assays for selecting molecules for increasing bone mineralization and methods for utilizing such molecules.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: July 12, 2011
    Assignee: Darwin Discovery Limited
    Inventors: Mary E. Brunkow, David J. Galas, Brian Kovacevich, John T. Mulligan, Bryan W. Paeper, Jeffrey Van Ness, David J. Winkler
  • Publication number: 20110150866
    Abstract: A novel class or family of TGF-? binding proteins is disclosed. Also disclosed are assays for selecting molecules for increasing bone mineralization and methods for utilizing such molecules.
    Type: Application
    Filed: October 31, 2007
    Publication date: June 23, 2011
    Applicant: Darwin Discovery Limited
    Inventors: Mary E. Brunkow, David J. Galas, Brian Kovacevich, John T. Mulligan, Bryan W. Paeper, Jeffrey Van Ness, David G. Winkler
  • Patent number: 7758858
    Abstract: Compositions and methods for increasing bone density using antibodies directed to a novel class or family of TGF-? binding proteins are provided. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases associated with a loss of bone density, for example osteoporosis.
    Type: Grant
    Filed: February 27, 2004
    Date of Patent: July 20, 2010
    Assignee: Darwin Discovery Ltd.
    Inventors: Mary E Brunkow, David J Galas, Brian Kovacevich, John T Mulligan, Bryan W Paeper, Jeffrey Van Ness, David G Winkler
  • Patent number: 7642344
    Abstract: Methods and compounds, including compositions therefrom, are provided for determining the sequence of nucleic acid molecules. The methods permit the determination of multiple nucleic acid sequences simultaneously. The compounds are used as tags to generate tagged nucleic acid fragments which are complementary to a selected target nucleic acid molecule. Each tag is correlative with a particular nucleotide and, in a preferred embodiment, is detectable by mass spectrometry. Following separation of the tagged fragments by sequential length, the tags are cleaved from the tagged fragments. In a preferred embodiment, the tags are detected by mass spectrometry and the sequence of the nucleic acid molecule is determined therefrom. The individual steps of the methods can be used in automated format, e.g., by the incorporation into systems.
    Type: Grant
    Filed: June 21, 2007
    Date of Patent: January 5, 2010
    Assignee: Operon Biotechnologies, Inc.
    Inventors: Jeffrey Van Ness, John C Tabone, J Jeffry Howbert, John T Mulligan
  • Patent number: 7572899
    Abstract: Nucleic acids relating to human TGF-? binding proteins are disclosed. Also disclosed are assays for selecting molecules for increasing bone mineralization and methods for utilizing such molecules.
    Type: Grant
    Filed: March 7, 2002
    Date of Patent: August 11, 2009
    Assignee: UCB SA
    Inventors: Mary E Brunkow, David J Galas, Brian Kovacevich, John T Mulligan, Bryan Paeper, Jeffrey Van Ness, David G Winkler
  • Publication number: 20080234219
    Abstract: A novel class or family of TGF-? binding proteins is disclosed. Also disclosed are assays for selecting molecules for increasing bone mineralization and methods for utilizing such molecules.
    Type: Application
    Filed: October 31, 2007
    Publication date: September 25, 2008
    Applicant: Darwin Discovery Limited
    Inventors: Mary E. Brunkow, David J. Galas, Brian Kovacevich, John T. Mulligan, Bryan W. Paeper, Jeffrey Van Ness, David G. Winkler
  • Publication number: 20080182788
    Abstract: A novel class or family of TGF-? binding proteins is disclosed. Also disclosed are assays for selecting molecules for increasing bone mineralization and methods for utilizing such molecules.
    Type: Application
    Filed: October 31, 2007
    Publication date: July 31, 2008
    Applicant: Darwin Discovery Limited
    Inventors: Mary E. Brunkow, David J. Galas, Brian Kovacevich, John T. Mulligan, Bryan W. Paeper, Jeffrey Van Ness, David G. Winkler
  • Publication number: 20080009613
    Abstract: Methods and compounds, including compositions therefrom, are provided for determining the sequence of nucleic acid molecules. The methods permit the determination of multiple nucleic acid sequences simultaneously. The compounds are used as tags to generate tagged nucleic acid fragments which are complementary to a selected target nucleic acid molecule. Each tag is correlative with a particular nucleotide and, in a preferred embodiment, is detectable by mass spectrometry. Following separation of the tagged fragments by sequential length, the tags are cleaved from the tagged fragments. In a preferred embodiment, the tags are detected by mass spectrometry and the sequence of the nucleic acid molecule is determined therefrom. The individual steps of the methods can be used in automated format, e.g., by the incorporation into systems.
    Type: Application
    Filed: June 21, 2007
    Publication date: January 10, 2008
    Applicant: Operon Biotechnologies, Inc.
    Inventors: Jeffrey Van Ness, John Tabone, J. Howbert, John Mulligan
  • Patent number: 7247434
    Abstract: Methods and compounds, including compositions therefrom, are provided for determining the sequence of nucleic acid molecules. The methods permit the determination of multiple nucleic acid sequences simultaneously. The compounds are used as tags to generate tagged nucleic acid fragments which are complementary to a selected target nucleic acid molecule. Each tag is correlative with a particular nucleotide and, in a preferred embodiment, is detectable by mass spectrometry. Following separation of the tagged fragments by sequential length, the tags are cleaved from the tagged fragments. In a preferred embodiment, the tags are detected by mass spectrometry and the sequence of the nucleic acid molecule is determined therefrom. The individual steps of the methods can be used in automated format, e.g., by the incorporation into systems.
    Type: Grant
    Filed: July 16, 2003
    Date of Patent: July 24, 2007
    Assignee: Operon Biotechnologies, Inc.
    Inventors: Jeffrey Van Ness, John C Tabone, J Jeffry Howbert, John T Mulligan
  • Patent number: 7192583
    Abstract: Antibodies to a novel family of TGF-? binding proteins are disclosed, for use in methods of altering bone density and bone mineralization, which methods are applicable to the treatment of diseases including osteopenia and osteoporosis.
    Type: Grant
    Filed: March 6, 2003
    Date of Patent: March 20, 2007
    Assignee: Darwin Discovery Ltd.
    Inventors: Mary E Brunkow, David J Galas, Brian Kovacevich, John T Mulligan, Bryan W Paeper, Jeffrey Van Ness, David G Winkler
  • Patent number: 7112423
    Abstract: The present invention provides methods and kits for amplifying target nucleic acids (including whole genomes) using nicking agents. In certain aspects, the amplification does not require the use of any external oligonucleotide primers that are capable of annealing to a portion of the target nucleic acid. This invention is useful in many areas such as genetic disease diagnoses, forensic analyses and palcoarcheological studies.
    Type: Grant
    Filed: July 15, 2002
    Date of Patent: September 26, 2006
    Assignee: Keck Graduate Institute
    Inventors: Jeffrey Van Ness, David J Galas, Lori K Van Ness
  • Patent number: 7052846
    Abstract: Tags and linkers specifically designed for a wide variety of nucleic acid reactions are disclosed, which are suitable for a wide variety of nucleic acid reactions wherein separation of nucleic acid molecules based upon size is required.
    Type: Grant
    Filed: June 19, 2003
    Date of Patent: May 30, 2006
    Assignee: Operon Biotechnologies, Inc.
    Inventors: Jeffrey Van Ness, John C Tabone, J Jeffry Howbert, John T Mulligan
  • Publication number: 20060057566
    Abstract: Tags and linkers specifically designed for a wide variety of nucleic acid reactions are disclosed, which are suitable for a wide variety of nucleic acid reactions wherein separation of nucleic acid molecules based upon size is required.
    Type: Application
    Filed: June 19, 2003
    Publication date: March 16, 2006
    Applicant: QIAGEN Genomics, Inc.
    Inventors: Jeffrey Van Ness, John Tabone, J. Howbert, John Mulligan
  • Publication number: 20050089850
    Abstract: The present invention provides genotyping analysis by liquid chromatographic analysis of short nucleic acid fragments. The nucleic acid fragments are amplification products using specifically designed oligonucleotides as primers and target nucleic acids containing nucleotides of interest as templates. The oligonucleotides contain recognition sequences for restriction endonucleases that cleave outside the recognition sequences. The short nucleic acid fragments can be rapidly and reliably analyzed using liquid chromatography, optionally followed by mass spectrometry, and the nucleotides of interest identified.
    Type: Application
    Filed: October 1, 2001
    Publication date: April 28, 2005
    Inventors: Jeffrey Van Ness, David Galas, Lori Garrison
  • Patent number: 6884586
    Abstract: The present invention provides methods and compositions for nucleic acid methylation analysis using nicking agents.
    Type: Grant
    Filed: July 15, 2002
    Date of Patent: April 26, 2005
    Assignee: Keck Graduate Institute
    Inventors: Jeffrey Van Ness, David J. Galas, Lori K. Van Ness
  • Patent number: 6815212
    Abstract: Methods are provided for detecting the binding of a first member to a second member of a ligand pair, comprising the steps of (a) combining a set of first tagged members with a biological sample which may contain one or more second members, under conditions, and for a time sufficient to permit binding of a first member to a second member, wherein said tag is correlative with a particular first member and detectable by non-fluorescent spectrometry, or potentiometry, (b) separating bound first and second members from unbound members, (c) cleaving the tag from the tagged first member, and (d) detecting the tag by non-fluorescent spectrometry, or potentiometry, and therefrom detecting the binding of the first member to the second member.
    Type: Grant
    Filed: October 24, 2001
    Date of Patent: November 9, 2004
    Assignee: Qiagen Genomics, Inc.
    Inventors: Jeffrey Van Ness, John C. Tabone, J. Jeffry Howbert, John T. Mulligan